These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2869578)

  • 21. Uncomplicated peptic ulcer disease. An overview of formation and treatment principles.
    Ziller SA; Netchvolodoff CV
    Postgrad Med; 1993 Mar; 93(4):126-8, 131-2, 137-40. PubMed ID: 8095330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of prostaglandins in the control of gastric acid secretion.
    Peskar BM
    Hepatogastroenterology; 1980 Aug; 27(4):330-6. PubMed ID: 7009357
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
    Konturek SJ; Dembinski A; Warzecha Z; Bielanski W; Brzozowski T; Drozdowicz D
    Gut; 1988 Jul; 29(7):894-902. PubMed ID: 3260885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mechanism of action of new drugs in ulcer therapy].
    Simon B; Fromm T; Kather H; Kommerell B
    Verh Dtsch Ges Inn Med; 1978; (84):984-7. PubMed ID: 742166
    [No Abstract]   [Full Text] [Related]  

  • 25. Gastroprotective and ulcer healing effects of solon, a synthetic flavonoid derivative of sophoradin.
    Konturek SJ; Mrzozowski T; Drozdowicz D; Pawlik W; Sendur R
    Hepatogastroenterology; 1987 Aug; 34(4):164-70. PubMed ID: 3478294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid and barriers. Current research and future developments for peptic ulcer therapy.
    Rademaker JW; Hunt RH
    Scand J Gastroenterol Suppl; 1990; 175():19-26. PubMed ID: 1978405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Local factors in the pathogenesis of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1988 May; 66(5):25-30. PubMed ID: 3047490
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of growth hormone-releasing factor and somatostatin on ulcer healing and mucosal growth in rats: role of gastrin and epidermal growth factor.
    Konturek SJ; Brzozowski T; Dembinski A; Warzecha Z; Konturek PK; Yanaihara N
    Digestion; 1988; 41(3):121-8. PubMed ID: 2906300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of gastric mucosal hexosamine in aspirin-induced ulcers.
    Moriga M; Aono M; Murakami M; Uchino H
    Gastroenterol Jpn; 1980; 15(1):1-6. PubMed ID: 7358257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH, healing rate and symptom relief in acid-related diseases.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1996; 69(2):159-74. PubMed ID: 9112748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teprenone promotes the healing of acetic acid-induced chronic gastric ulcers in rats by inhibiting neutrophil infiltration and lipid peroxidation in ulcerated gastric tissues.
    Kobayashi T; Ohta Y; Yoshino J; Nakazawa S
    Pharmacol Res; 2001 Jan; 43(1):23-30. PubMed ID: 11207062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric antisecretory and antiulcer agents.
    Bass P
    Adv Drug Res; 1974; 8():205-334. PubMed ID: 4142832
    [No Abstract]   [Full Text] [Related]  

  • 33. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ„ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA
    Sov Med; 1991; (3):39-43. PubMed ID: 1909055
    [No Abstract]   [Full Text] [Related]  

  • 35. The lack of effects of somatostatin on gastric responses induced by electrical vagal stimulation.
    Cho CH; Chen SW; Chen SM; Ho LT
    Pharmacol Biochem Behav; 1983 Dec; 19(6):925-7. PubMed ID: 6140685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of ulcer healing in gastrointestinal tract: its pathophysiology and clinical relevance.
    Arakawa T; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Morimoto K
    World J Gastroenterol; 2012 Sep; 18(35):4811-22. PubMed ID: 23002355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are prostaglandins truly "cytoprotective"?
    Morris GP
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):326-30. PubMed ID: 3760515
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidermal growth factor in gastric ulcer healing by nocloprost, a stable prostaglandin E2 derivative.
    Konturek JW; Hengst K; Konturek SJ; Domschke W
    Scand J Gastroenterol; 1997 Oct; 32(10):980-4. PubMed ID: 9361169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of some Sitavirya drugs on gastric secretion and ulceration.
    De B; Maiti RN; Joshi VK; Agrawal VK; Goel RK
    Indian J Exp Biol; 1997 Oct; 35(10):1084-7. PubMed ID: 9475045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Protection of the gastric mucosa by prostaglandins--is this physiologic concept suitable for ulcer therapy?].
    Schepp W
    Leber Magen Darm; 1986 Jan; 16(1):41-50. PubMed ID: 3959724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.